Journey Strategic Wealth’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.96M | Hold |
13,078
| – | – | 0.13% | 59 |
|
|
2025
Q1 | $4.33M | Hold |
13,078
| – | – | 0.15% | 48 |
|
|
2024
Q4 | $4.04M | Sell |
13,078
-250
| -2% | -$77.1K | 0.15% | 43 |
|
|
2024
Q3 | $2.83M | Buy |
13,328
+3
| +0% | +$637 | 0.1% | 51 |
|
|
2024
Q2 | $3.73M | Buy |
13,325
+5
| +0% | +$1.4K | 0.16% | 32 |
|
|
2024
Q1 | $3.56M | Hold |
13,320
| – | – | 0.16% | 31 |
|
|
2023
Q4 | $3.08M | Hold |
13,320
| – | – | 0.15% | 29 |
|
|
2023
Q3 | $1.95M | Sell |
13,320
-31
| -0.2% | -$4.53K | 0.09% | 35 |
|
|
2023
Q2 | $3.08M | Sell |
13,351
-503
| -4% | -$116K | 0.14% | 29 |
|
|
2023
Q1 | $3.36M | Sell |
13,854
-7
| -0.1% | -$1.7K | 0.35% | 23 |
|
|
2022
Q4 | $4.02M | Buy |
13,861
+36
| +0.3% | +$10.4K | 0.47% | 20 |
|
|
2022
Q3 | $898K | Buy |
13,825
+5
| +0% | +$325 | 0.12% | 46 |
|
|
2022
Q2 | $989K | Hold |
13,820
| – | – | 0.13% | 41 |
|
|
2022
Q1 | $1.36M | Hold |
13,820
| – | – | 0.15% | 20 |
|
|
2021
Q4 | $1.17M | Buy |
+13,820
| New | +$1.17M | 0.12% | 38 |
|